Patients with liver cirrhosis or BCLC stage B had a worse prognosis (P = 0.0031 and P=0.0145) and the other conventional clinicopathological features, such as gender, age, AFP levels, HBsAg, ALT, tumor size and tumor number, none of them could predict the DFS (Table 3). This evidence concerns the gene AFP and cirrhosis of liver.